Introduction
In connection with our program of preparing heterocyclic compounds which might have potential biological activities [1] [2] [3] [4] [5] [6] [7] . The reaction of activated nitriles with 2-thiazolidine derivatives has previously claimed to afford the thiazolopyrimidine derivatives in moderate yield [8, 9] . We report here that no thiazolopyrimidine 3' could be isolated in the reaction of α-cyano-3,4,5-trimethoxy cinnamonitrile and/or ethyl-α-cyano-3,4,5-trimethoxy cinnamate (1a,b) with 2-imino-4-oxo-2-thiazolidine 2 and instead we have found that the reaction product in all cases was 5-arylmethylene-2-imino-4-oxo-2-thiazolidine 3.
Experimental
All melting points are uncorrected. The infrared spectra are recorded on FTIR Maltson (infinity series) spectrometers as KBr discs. The 1 H NMR spectra were measured on Varian Gemini 200 MHz instrument with chemical shift () expressed in ppm downfield from TMS. Mass spectra were recorded on Shimaduzu GC-MS, QP 1000 EX instrument operating at 70 eV. TLC was run using TLC aluminum sheets silica gel F254 (Merck).
(
Z)-2-Imino-5-(3,4,5-trimethoxybenzylidene)-thiazolidin-4-one (3):
A mixture of iminothiazolidinone 2 (1.16 g, 10 mmole), 0.5 mL piperidine, α-cyano-3,4,5-trimethoxy cinnamonitrile 1a and/or ethyl-α-cyano-3,4,5-trimethoxy cinnamate 1b (10 mmole) was refluxed in 30 mL absolute ethanol for 6h. The solid product deposited on hot was filtered off, washed with hot water, dried and recrystallized from n-butanol as yellow crystals (Scheme 1 [5-(3,4,5- A solution of phenyl magnesium bromide or cyclohexyl magnesium bromide (15 mmole) in anhydrous ether (100 mL) was added dropwise while shaking to a warm solution of 4-oxo-2-thiazoline 6 (1.81 g, 5 mmole) in anhydrous benzene (100 mL). The whole mixture warmed over a water-bath for 10 hours and left standing at room temperature for 24 hours. The Grignard complex was decomposed with a saturated solution of ammonium chloride (200 mL) and extracted with ether (200 mL). The combined ether-benzene extract was washed thoroughly with water, dried over anhydrous sodium sulphate and evaporated. The viscous oil which remained was triturated several times with light petroleum-ether (B.p.: 40-60 °C) and the remain insoluble fraction was dissolved in a suitable solvent to give 7 and 8, respectively. ( 
2-Phenyl-5-[phenyl(3,4,5-trimethoxyphenyl)methyl]-2-(piperidin-1-yl)-thiazolidin-4-one

Z)-5-(3,4,5-trimethoxybenzyli-dene)-2-chloro-3-(furan-2-carbonyl)-4-oxothiazolidin-2-yl furan-2-carboxylate (13)
:
Results and discussion
5-Arylmethylene-2-imino-4-oxo-2-thiazolidine 3 obtained as the sole product in a good yield upon treatment of 2-imino-4-oxo-2-thiazolidine (2) with α-cyano-3,4,5-trimethoxy cinnamonnitrile and/or ethyl-α-cyano-3,4,5-trimethoxy cinnamate (1a,b) in refluxing ethanol in the presence of catalytic amount of piperidine (Scheme 1). Structure of compound 3 was substantiated from microanalytical data and was confirmed by infrared, 1 H NMR, 13 C NMR and mass spectra (c.f. Exp.).
The configuration assigned to the exocyclic C=C double bond in compound 3 (Z-configuration) has been proven by 1 H NMR calculations [10] which are compatible with the observed data given in the experimental part. Furthermore, the negative field of the carbonyl oxygen suffers from the repulsive forces with the π-cloud of the aromatic ring in case of E-configuration and hence the compound favours the formation of the structure shown in Scheme 1.
The formation of 3 was assumed to proceed via nucleophilic addition of the thiazolidinyl-C-5 to the β-carbon of the activated double bond of 1 forming the 1:1 adduct followed by removal of malononitrile or ethylcyanoacetate molecule (Scheme 2).
When (Z)-2-imino-5-(3,4,5-trimethoxybenzylidene)-thiazolidin-4(H)-one (3) was subjected to react with benzyl amine in refluxing ethanol, H2S released during the reaction period and a sulfur free compound with molecular formula C27H25N3O4 is produced which indicates the incorporation of two molecules of benzyl amine. This compound was identified to be (2E, 5Z)-1-benzyl-2-benzylimino-5-(3,4,5-trimethoxy benzylidene)-imidazolidin-4(H)one (4) from microanalytical data and spectroscopic analysis (Scheme 3).
Differing accounts dealing with action of hydrazine hydrate on thiazolidinone derivatives were reported [11] [12] [13] . Omer and Rauof et al. [12] reported the cleavage of 5-arylmethylene-2,4-dioxo-1,3-thiazolidines with hydrazines and afforded the respective triazinones. Here in, hydrazinolysis of compound 3 in refluxing n-butanol afforded the dimeric product 5 (Scheme 3).
Several authors reported the formation of piperidino and morpholino salts of 5-arylmethylene-4-oxo-2-thioxo-thiazolidines by reacting 3H-thiazolinones with the required secondary amine in acetone or methyl acetate solution [11, 12] . Treatment of (Z)-2-imino-5-(3,4,5-trimethoxybenzylidene)-thiazolidin-4-one (3) with piperidine afforded the compound 6 which assigned as (Z)-2-(piperidin-1-yl)-5-(3,4,5-trimethoxy benzylidene)thiazol-4(5H)one (c.f. Exp.).
The reaction of Grignard reagents with various 5-arylidene-1,3-thiazolidines and its piperidino salts have been reported [14] . Actually, the majority of the products resulted from the action of cyclohexyl magnesium bromide and phenyl magnesium bromide on 6 represents some of the mentioned routes (1,2-addition at C=N, C=O and 1,4-addition to C=C-C=O and C=C-C=N). Thus, the reaction of 6 with phenyl magnesium bromide in refluxing ether-anhydrous benzene mixture afforded the adduct 7.
The structure of 7 was evidenced by analytical data which infers the incorporation of two molar proportions of the Grignard reagent. The transformation of 6 to 7 was represented in scheme 4, it is supported that the reaction has occurred either through 1,2-addition to C=N group of the thiazolidine ring, or through the transition state [A] which resulted from the 1,4-addition to C=C-C=O ring system followed by rearrangement (Scheme 4).
Cyclohexyl magnesium bromide attacks 2-piperidino derivative 6 in refluxing ether-anhydrous benzene mixture through 1,2-addition at C=N to give (Z)-2-cyclohexyl-2-(piperidin-1-yl)-5-(3,4,5-trimethoxybenzylidene)-thiazolidin-4-one (8) . The structure of 8 is substantiated by microanalysis which infers the addition of one molecule of cyclohexane and confirmed by IR spectrum which exhibits the strong absorption bands characteristic for NH (br.), C-H (str.), and C=O of thiazolidine ring and was rigidly established by mass spectrum which shows fragmentation pattern consistent with the assigned structure 8 (c.f. Exp.). The carbanion which derived from ethyl cyanoacetate in anhydrous benzene upon treating with sodium hydride reacted with compound 6 to afford orange solid product from which it is possible to isolate (Z)-2-[4-oxo-2-(piperidin-1-yl)-5-(3,4,5-trimethoxybenzylidene)-thiazolidin-2-yl]malonic acid (9) . Conversion of 6 into the potassium salt 10 have been done on the basis of higher acidity of 3H-compound following the reported method [12] by treating 6 with ethanolic potassium hydroxide solution. Formation of the salt 9 infers that the substituent at the 2-position was replaced through the reaction (Scheme 5).
The IR spectrum of 10 show νC=O at relative lower frequency (1652 cm -1 ) as compared with the extra conjugation performed by the newly formed negative charge. Furthermore, 1 H NMR spectrum of 10 show only resonances of aromatic protons (2H) at δ 7.84 ppm together with olefinic proton at δ 7.66 ppm, and two singlets for three methoxy protons (9H) at δ (ranged from 3.9-3.8 ppm which consistent with the proposed structure. (Z)-5-(3,4,5-trimethoxybenzylidene)-3H-thiazolidin-2,4-dione (11) was obtained upon treating the potassium salt 10 with dilute acetic acid.
Alkylation of 10 with ethyl chloroacetate in boiling ethanol affords the N-alkylation product (Z)ethyl-2-[2,4-dioxo-5-(3,4,5-trimethoxybenzylidene)-thiazolidin-3-yl]acetate (12) . Acylation of 10 with furoyl chloride in pyridine gave a yellow crystals product 13 after reflux for four hours (TLC). Full analysis for 13 using spectroscopic methods indicates the incorporation of two moles of the acid chloride with loss of KCl.
